Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp

Bullboard Posts

Comment by ProsperityPeteon Sep 20, 2011 12:03pm

279 Views

Post# 19061728

RE: Great Bear starts phase 1 drilling at Etzel

At 18 cents, Great Bear Resources has excellent leverage. Considering Etzel is along strike with the Klaza and the Charlotte properties, it should be rather simple for GBR to define the highest priority targets to drill. Etzel could bring a nice pop to ACP and GBR. Looks like GBR is well into their drilling at Etzel and there is now lots to look forward too. The 2011 Yukon drilling season is far from over.

Good luck to all longs,

Pete

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading